



• The global Anlotinib market size was valued at US$ 287.4 million in 2024 and is projected to reach US$ 512.6 million by 2030, at a CAGR of 10.1% during the forecast period 2024-2030.


• United States Anlotinib market size was valued at US$ 18.6 million in 2024 and is projected to reach US$ 37.2 million by 2030, at a CAGR of 12.3% during the forecast period 2024-2030.


